+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heart Transplant Market by Transplant Type, Graft Preservation, Product, Patient Age Group, End User, Indication - Global Forecast 2026-2032- Product Image
Heart Transplant Market by Transplant Type, Graft Preservation, Product, Patient Age Group, End User, Indication - Global Forecast 2026-2032- Product Image
Sale

Heart Transplant Market by Transplant Type, Graft Preservation, Product, Patient Age Group, End User, Indication - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904528
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Heart Transplant Market is projected to reach USD 15.86 Billion in 2026. It is expected to continue growing at a CAGR of 10.41%, reaching USD 28.85 Billion by 2032.

Heart transplantation remains the definitive therapy for selected patients with end-stage heart failure when guideline-directed medical therapy, device therapy, and durable mechanical circulatory support no longer provide adequate survival or quality-of-life benefit. Demand is structurally high as heart failure prevalence rises with population aging, diabetes, hypertension, ischemic heart disease, congenital heart disease survival, and improved cardiomyopathy diagnosis rates.

The heart transplant ecosystem is constrained by donor-organ availability, transplant-center capacity, immunologic matching, perioperative risk, and lifelong immunosuppression needs. Verified registry evidence from OPTN/SRTR and the International Society for Heart and Lung Transplantation shows that annual transplant activity has increased in high-capacity markets, while waitlist pressure, donor conversion, and regional access gaps remain defining clinical and commercial challenges.

Transformative Shifts in the Heart Transplant Landscape

The landscape is shifting from a scarcity-managed model toward a technology-enabled organ utilization model. Donation after circulatory death, normothermic machine perfusion, improved donor assessment, and better logistics are enabling transplant programs to evaluate donor hearts that previously may not have been used, particularly in mature markets with strong procurement networks and specialized cardiac teams.

Policy and payment changes are also reshaping competition. Allocation frameworks increasingly prioritize urgency, broader sharing, measurable outcomes, and equitable access, while hospitals face growing scrutiny on survival, readmissions, infection control, rejection surveillance, and cost efficiency. These shifts favor transplant centers and suppliers that combine clinical excellence with data infrastructure, rapid transport coordination, and post-transplant monitoring capabilities.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative capability across the heart transplant pathway rather than a single product category. AI-enabled analytics can support candidate risk stratification, donor-recipient matching, imaging interpretation, hemodynamic trend analysis, donor-heart suitability assessment, and early detection of rejection or infection signals from electronic health records, laboratory data, wearables, biopsies, and molecular diagnostics outputs.

The strongest near-term value is decision support, not autonomous decision-making. Industry leaders must validate algorithms against registry-grade outcomes, reduce bias in underrepresented populations, preserve clinician oversight, and comply with medical-device, privacy, and cybersecurity regulations. Programs that integrate AI with transplant registry data, multidisciplinary review, and clinical governance are best positioned to improve organ utilization, patient surveillance, and long-term graft survival.

Key Regional Insights

Asia-Pacific is expanding through rising tertiary-care investment, larger heart failure populations, and growing transplant programs in China, India, Japan, South Korea, and Australia, although deceased-donor availability, public awareness, allocation governance, and reimbursement consistency vary widely. North America remains the highest-capacity region, led by the United States and Canada, supported by mature organ procurement networks, advanced mechanical circulatory support, established transplant-center accreditation, and robust outcomes reporting through national registries.

Latin America shows selective growth through established programs in Brazil and Mexico, but access remains uneven due to infrastructure gaps, donor conversion challenges, ICU capacity, and financing constraints. Europe benefits from national transplant authorities, public reimbursement, cross-border collaboration, and organ-sharing frameworks such as Eurotransplant, while the Middle East is investing in specialty cardiac centers, organ donation regulations, and advanced heart failure services. Africa remains an underpenetrated region where heart transplant activity is concentrated in a limited number of centers and constrained by workforce availability, critical-care infrastructure, donor-system maturity, and long-term immunosuppression access.

Key Group Insights

ASEAN markets are characterized by growing cardiovascular disease burden and improving tertiary hospitals, but heart transplant capacity remains concentrated in more advanced health systems with established deceased-donor programs, transplant governance, and post-operative intensive care. The GCC is accelerating investment in cardiac centers, transplant regulations, national donor registries, and advanced heart failure services, supported by health transformation strategies and rising demand for complex cardiovascular care.

The European Union benefits from harmonized regulatory standards, public funding, organ-sharing collaboration, and strong clinical research networks, making it a critical hub for transplant protocols, perfusion technologies, immunosuppression management, and post-transplant surveillance. BRICS countries represent large long-term demand pools, with China, India, and Brazil particularly important because of their expanding cardiovascular disease burden and increasing transplant-system capacity. G7 countries lead in research intensity, reimbursement depth, device adoption, registry transparency, and clinical guideline implementation, while NATO member markets overlap with many high-income systems that prioritize resilient medical supply chains, critical-care readiness, emergency preparedness, and cross-border clinical cooperation.

Key Country Insights

The United States leads global heart transplant activity by annual procedure volume, with OPTN data reporting more than 4,500 heart transplants performed in 2023, supported by a national allocation system, established organ procurement organizations, broad use of mechanical circulatory support, and detailed outcomes reporting. Canada maintains strong outcomes through regional transplant programs, public reimbursement, and coordinated donation systems, while Mexico and Brazil provide important Latin American capacity despite regional variation in access, donor availability, and specialized center distribution.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate mature transplant systems with strong public-sector coordination, established cardiac surgery expertise, and structured post-transplant follow-up, while Russia has growing specialized capacity but variable public transparency compared with Western European registries. In Asia-Pacific, China is scaling transplant services under evolving donation reforms and greater national oversight, India has high unmet need with expanding public and private programs, Japan emphasizes strict allocation rules and high-quality outcomes within a constrained donor environment, Australia has established national coordination and advanced retrieval logistics, and South Korea combines advanced hospital infrastructure with strong cardiovascular specialty care and growing transplant capability.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize organ utilization, outcomes transparency, and integrated post-transplant care. Investments in ex vivo perfusion, donor-heart assessment, rapid logistics, molecular rejection surveillance, infection management, immunosuppression optimization, medication adherence support, and remote monitoring can directly address the core constraints of donor scarcity and long-term graft preservation.

Commercial strategies should be tailored by market maturity. In established markets, differentiation should focus on evidence generation, AI-enabled workflow integration, value-based partnerships with transplant centers, and interoperability with registry and hospital data systems. In emerging markets, organizations should support workforce training, registry development, procurement-system strengthening, quality standards, and affordable financing models that expand safe access without compromising clinical quality.

Research Methodology

This executive summary is based on secondary research from verified public and institutional sources, including transplant registries, peer-reviewed clinical literature, health ministry publications, organ procurement organizations, international transplant societies, and regulatory agencies. Core reference frameworks include OPTN/SRTR, ISHLT registry reporting, Eurotransplant and national transplant authority data, WHO health-system indicators, and published heart failure epidemiology.

The analysis applies triangulation across procedure activity, clinical outcomes, policy changes, reimbursement structures, technology adoption, organ donation frameworks, and regional capacity indicators. Insights were screened for factual consistency, recency, and relevance to heart transplantation, advanced heart failure management, organ preservation, immunosuppression, diagnostics, digital health, and transplant-center operations.

Conclusion

The heart transplant landscape is advancing through the convergence of clinical innovation, organ-preservation technology, digital decision support, and stronger transplant-system governance. The central challenge remains unchanged: demand for suitable donor hearts exceeds supply, making every improvement in organ identification, preservation, allocation, implantation, and post-transplant management strategically important.

Organizations that align evidence-based technologies with transplant workflow realities will capture the strongest opportunities. The future competitive landscape will reward measurable improvements in donor-heart utilization, equitable access, survival outcomes, cost efficiency, regulatory readiness, and lifelong patient monitoring.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Heart Transplant Market, by Transplant Type
7.1. Heterotopic Transplant
7.2. Orthotopic Transplant
7.2.1. Biatrial Technique
7.2.2. Bicaval Technique
7.3. Heart-Lung Transplant
8. Heart Transplant Market, by Graft Preservation
8.1. Machine Perfusion
8.1.1. Hypothermic Perfusion
8.1.2. Normothermic Perfusion
8.2. Static Cold Storage
9. Heart Transplant Market, by Product
9.1. Donor-Based Transplantation
9.1.1. Donation After Brain Death (DBD)
9.1.2. Donation After Circulatory Death (DCD)
9.2. Mechanical Circulatory Support
9.2.1. Left Ventricular Assist Devices (LVAD)
9.2.2. Right Ventricular Assist Devices (RVAD)
9.2.3. Biventricular Assist Devices (BiVAD)
9.3. Total Artificial Heart
9.4. Organ Preservation & Transport Systems
10. Heart Transplant Market, by Patient Age Group
10.1. Adult
10.2. Geriatric
10.3. Pediatric
11. Heart Transplant Market, by End User
11.1. Hospitals
11.2. Transplant Centers
11.3. Specialty Cardiac Centers
12. Heart Transplant Market, by Indication
12.1. Congenital Heart Disease
12.2. Dilated Cardiomyopathy
12.3. End Stage Heart Failure
12.4. Ischemic Cardiomyopathy
12.5. Valvular Heart Disease
13. Asia-Pacific Heart Transplant Market
14. North America Heart Transplant Market
15. Latin America Heart Transplant Market
16. Europe Heart Transplant Market
17. Middle East Heart Transplant Market
18. Africa Heart Transplant Market
19. ASEAN Heart Transplant Market
20. GCC Heart Transplant Market
21. European Union Heart Transplant Market
22. BRICS Heart Transplant Market
23. G7 Heart Transplant Market
24. NATO Heart Transplant Market
25. United States Heart Transplant Market
26. Canada Heart Transplant Market
27. Mexico Heart Transplant Market
28. Brazil Heart Transplant Market
29. United Kingdom Heart Transplant Market
30. Germany Heart Transplant Market
31. France Heart Transplant Market
32. Russia Heart Transplant Market
33. Italy Heart Transplant Market
34. Spain Heart Transplant Market
35. China Heart Transplant Market
36. India Heart Transplant Market
37. Japan Heart Transplant Market
38. Australia Heart Transplant Market
39. South Korea Heart Transplant Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. Becton, Dickinson and Company
41.3. Berlin Heart GmbH
41.4. BiVACOR, Inc.
41.5. Boston Scientific Corporation
41.6. Braile Biomédica Indústria Comércio E Representações Ltda.
41.7. BrioHealth Solutions, Inc.
41.8. CARMAT SAS
41.9. CH Biomedical, Inc.
41.10. EUROSETS S.R.L.
41.11. FineHeart
41.12. Fresenius Medical Care AG
41.13. Getinge AB
41.14. Hemovent GmbH
41.15. Jarvik Heart, Inc.
41.16. Johnson & Johnson
41.17. LivaNova PLC
41.18. magAssist Co., Ltd.
41.19. Medtronic plc
41.20. MicroPort Scientific Corporation
41.21. ReliantHeart, Inc.
41.22. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
41.23. Shenzhen Core Medical Technology Co., Ltd.
41.24. Sun Medical Technology Research Corp.
41.25. SynCardia Systems, LLC
41.26. Terumo Corporation
List of Figures
FIGURE 1. GLOBAL HEART TRANSPLANT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HEART TRANSPLANT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HEART TRANSPLANT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HEART TRANSPLANT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 25. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HEART TRANSPLANT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MACHINE PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MACHINE PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MACHINE PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 137. EUROPE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 140. EUROPE HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 142. EUROPE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 143. EUROPE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 156. AFRICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. AFRICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 158. AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 159. AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 160. AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 161. AFRICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. AFRICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 163. AFRICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 164. AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 165. AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 167. ASEAN HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. ASEAN HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 169. ASEAN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 170. ASEAN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 171. ASEAN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 172. ASEAN HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 173. ASEAN HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 174. ASEAN HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 175. ASEAN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 176. ASEAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. ASEAN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 178. GCC HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GCC HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 180. GCC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 181. GCC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 182. GCC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 183. GCC HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 184. GCC HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 185. GCC HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 186. GCC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. GCC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. GCC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 200. BRICS HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. BRICS HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 202. BRICS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 203. BRICS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 204. BRICS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 205. BRICS HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 206. BRICS HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 207. BRICS HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 208. BRICS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 209. BRICS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. BRICS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 211. G7 HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. G7 HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 213. G7 HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 214. G7 HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 215. G7 HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 216. G7 HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 217. G7 HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 218. G7 HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 219. G7 HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 220. G7 HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. G7 HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 222. NATO HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. NATO HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 224. NATO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 225. NATO HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 226. NATO HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 227. NATO HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 228. NATO HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 229. NATO HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 230. NATO HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 231. NATO HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. NATO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 244. CANADA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 245. CANADA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 246. CANADA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 247. CANADA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 248. CANADA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 249. CANADA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 250. CANADA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 251. CANADA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 252. CANADA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 253. CANADA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. CANADA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 255. MEXICO HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 256. MEXICO HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 257. MEXICO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 258. MEXICO HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 259. MEXICO HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 260. MEXICO HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 261. MEXICO HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 262. MEXICO HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 263. MEXICO HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 264. MEXICO HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. MEXICO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 266. BRAZIL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 267. BRAZIL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 268. BRAZIL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 269. BRAZIL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 270. BRAZIL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 271. BRAZIL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 272. BRAZIL HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 273. BRAZIL HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 274. BRAZIL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 275. BRAZIL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. BRAZIL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 282. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 284. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 286. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 288. GERMANY HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 289. GERMANY HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 290. GERMANY HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 291. GERMANY HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 292. GERMANY HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 293. GERMANY HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 294. GERMANY HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 295. GERMANY HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 296. GERMANY HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 297. GERMANY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 298. GERMANY HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 299. FRANCE HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 300. FRANCE HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 301. FRANCE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 302. FRANCE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 303. FRANCE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 304. FRANCE HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 305. FRANCE HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 306. FRANCE HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 307. FRANCE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 308. FRANCE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. FRANCE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 310. RUSSIA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 311. RUSSIA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 312. RUSSIA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 313. RUSSIA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 314. RUSSIA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 315. RUSSIA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 316. RUSSIA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 317. RUSSIA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 318. RUSSIA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 319. RUSSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 320. RUSSIA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 321. ITALY HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 322. ITALY HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 323. ITALY HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 324. ITALY HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 325. ITALY HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 326. ITALY HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 327. ITALY HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 328. ITALY HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 329. ITALY HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 330. ITALY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 331. ITALY HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 332. SPAIN HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 333. SPAIN HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 334. SPAIN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 335. SPAIN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 336. SPAIN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 337. SPAIN HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 338. SPAIN HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 339. SPAIN HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 340. SPAIN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 341. SPAIN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 342. SPAIN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 343. CHINA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 344. CHINA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 345. CHINA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
TABLE 346. CHINA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
TABLE 347. CHINA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
TABLE 348. CHINA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 349. CHINA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
TABLE 350. CHINA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
TABLE 351. CHINA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 352. CHINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 353. CHINA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 354. INDIA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 355. INDIA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 356. IN

Companies Mentioned

The companies featured in this Heart Transplant market report include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Boston Scientific Corporation
  • Braile Biomédica Indústria Comércio E Representações Ltda.
  • BrioHealth Solutions, Inc.
  • CARMAT SAS
  • CH Biomedical, Inc.
  • EUROSETS S.R.L.
  • FineHeart
  • Fresenius Medical Care AG
  • Getinge AB
  • Hemovent GmbH
  • Jarvik Heart, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • magAssist Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • ReliantHeart, Inc.
  • SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
  • Shenzhen Core Medical Technology Co., Ltd.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages193
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 15.86 Billion
Forecasted Market Value ( USD ) by 2032 $ 28.85 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Heart Transplant Market Report 2026 - Product Image

Heart Transplant Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Market by Product Type, Therapy Type, Transplant Type, Route of Administration, Dosage Form, Regimen Type, End User, Patient Type, Distribution Channel - Global Forecast 2026-2032 - Product Image

Organ Transplant Immunosuppressant Drugs Market by Product Type, Therapy Type, Transplant Type, Route of Administration, Dosage Form, Regimen Type, End User, Patient Type, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Organ Transplant Diagnostics Market - Global Forecast 2026-2032 - Product Image

Organ Transplant Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report - Product Image

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

  • Report
  • 253 Pages
  • Global
From
Organ Transplantation Market Outlook 2026-2034: Market Share and Growth Analysis by Organ Type (Kidney, Liver, Heart, Lung, Pancreas, Intestine), Donor Type, Type of Transplant, Organ-Preservation Technique - Product Image

Organ Transplantation Market Outlook 2026-2034: Market Share and Growth Analysis by Organ Type (Kidney, Liver, Heart, Lung, Pancreas, Intestine), Donor Type, Type of Transplant, Organ-Preservation Technique

  • Report
  • 160 Pages
  • Global
From

About the Heart Transplant Market

The Heart Transplant market is a subset of the larger Surgical Procedures market. It involves the surgical replacement of a diseased or damaged heart with a healthy donor heart. The procedure is typically performed on patients with end-stage heart failure, and is considered a last resort when other treatments have failed. The process of transplantation involves a complex series of steps, including donor selection, organ procurement, and post-operative care. The Heart Transplant market is highly regulated, with strict guidelines in place to ensure the safety of both the donor and recipient. The success of the procedure is largely dependent on the skill of the medical team, as well as the availability of suitable donor organs. Some of the companies in the Heart Transplant market include Medtronic, Abbott, Edwards Lifesciences, and St. Jude Medical. These companies provide a range of products and services related to the procedure, including heart-assist devices, heart valves, and other medical devices. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.